This review describes the various methods available to diagnose left ventricular hypertrophy in hypertensive patients, emphasizing their strengths and clinical applications.
Answers are grounded in this paper and cite their sources.
Offers synthesis of LVH diagnostics in hypertension; leaves open optimal method for risk stratification in practice.
The presence of left ventricular hypertrophy (LVH) in hypertension, as detected by the electrocardiogram or echocardiography, is associated with an increased risk of mortality and morbidity several times above and beyond the risk of hypertension alone. The LIFE (Losartan Intervention For Endpoint reduction in hypertension) study confirmed that pharmacological agents, which reduce LVH, confer further reduction in morbidity and mortality. This makes the identification of patients with LVH all the more important. In this article we describe the various methods available to diagnose the presence of LVH in patients with hypertension, and consider their strengths and their place in clinical practice and in research.
No takes yet. Share an insight, caveat, or question.
Alfakih et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: